Hemophilia B with Inhibitor
Rare Diseases
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2023
2024
2025
2026
Centessa PharmaceuticalsSerpinPC
Clinical Trials (1)
A Study of SerpinPC in Participants with Hemophilia B (HemB) with Inhibitors
Start: Jul 2023Est. completion: Feb 2025
Phase 2Terminated
Related Jobs in Rare Diseases
Regional Gene Therapy Liaison - East Coast
Krystal Biotech
1h ago
Regional Gene Therapy Liaison - East Coast
Krystal Biotech
1h ago
Director, Clinical Development Operations Program Lead
Stoke Therapeutics
Bedford, Massachusetts, United States
1h ago
$236K - $260K/yr
Manager, Gene Therapy Operations (GTO)
Genetix Biotherapeutics
13h ago
From $130K/yr
Manager, Gene Therapy Operations (GTO)
Genetix Biotherapeutics
Somerville, Massachusetts, United States
13h ago
Ultra-Rare Disease Territory Account Specialist – Denver, CO
Novartis
Field Sales (USA)
Yesterday
$132K - $246K/yr
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space